Peripartum Cardiomyopathy: From Pathopysiology to Management: Chapter 3: Risk Stratification in Patients newly diagnosed with peripartum cardiomyopathy
Peripartum Cardiomyopathy, 2021, Pages 21-31
This book chapter advances SDG 3 by explaining how peripartum cardiomyopathy (PPCM) is a significant cause of pregnancy-associated morbidity and mortality.
Sex Differences in Cardiac Disease: Pathophysiology, Presentation, Diagnosis and Management: Chapter 25: Sex Hormones and Their Impact on Cardiovascular Health
Sex Differences in Cardiac Diseases, 2021, Pages 539-565
This book chapter advances SDG 3 by explaining how sex steroids (hormones), through their interactions with the sex steroid receptors present in the heart and vasculature, and their metabolic effects, play a vital role in cardiovascular (CV) health.
Organ Repair and Regeneration: Preserving Organs in the Regenerative Medicine Era: Chapter 14: How the Transplant Landscape is changing in the regenerative medicine era
Organ Repair and Regeneration, 2021, Pages 273-284
This book chapter advances SDG 3 by explaining how there are many strategies that have been implemented to increase the transplant donor pool, yet the gap between the demand and the offer remains too wide and, as a consequence, the number of patients dying on the waiting list keeps rising.
Stem Cells: Scientific Facts and Fiction, Third Edition: Chapter 16: Stem cell perspectives: a vision of the future
Stem Cells, Third Edition, 2021, Pages 383-399
This book chapter advances SDG 3 by explaining how many scientists share the conviction that human stem cell technology and greater understanding of stem cell biology will in the coming decades fulfill much of its promise and revolutionise medicine as we know it today, improving patient care without past precedent.
Translational Biotechnology, 2021, Pages 53-77
This book chapter advances SDG 3 by explaining how the role of biotechnology as a forerunner in the pathway of revolution of human lives has been promising in the recent past. The achievements of biotechnology in the bio-medical front encompass various products like novel vaccines, diagnostic devices, and novel therapeutic strategies.
Comprehensive Nanoscience and Nanotechnology, Second Edition, Volume 3: Section 3.04 - Antibacterial Nanoparticles
Gemma C. Cotton, Natalie R. Lagesse, Liam S. Parke, Carla J. Meledandri, 3.04 - Antibacterial Nanoparticles, Editor(s): David L. Andrews, Robert H. Lipson, Thomas Nann, Comprehensive Nanoscience and Nanotechnology (Second Edition), Academic Press, 2019, Pages 65-82
This chapter advances SDGs 3 and 6 by showing how increasing bacterial resistance to commonly used antibiotics is a pressing threat to the human population on a global scale. As the development of new combative drugs is complex, expensive, time consuming and risky, there has been a strong focus in recent years to develop alternative strategies for the treatment of bacterial infections, and nanoscale materials have emerged a strong contender for this purpose.
Elsevier, American Journal of Preventive Medicine, Volume 60, January 2021
Introduction: Although vaccination coverage is high in Kenya relative to other African nations, undervaccinated children remain, making it important to identify characteristics of these children and t
Elsevier, Journal of the American Medical Directors Association, Volume , 2021
Objective: Health disparities are pervasive in nursing homes (NHs), but disparities in NH end-of-life (EOL) care (ie, hospital transfers, place of death, hospice use, palliative care, advance care pla
Elsevier, Blood, Volume 137, 28 January 2021
Neighborhood poverty and pediatric allogeneic hematopoietic cell transplantation outcomes: A CIBMTR analysis
Social determinants of health, including poverty, contribute significantly to health outcomes in the United States; however, their impact on pediatric hematopoietic cell transplantation (HCT) outcomes
Elsevier, The Lancet Planetary Health, Volume 5, January 2021
Health and economic impact of air pollution in the states of India: the Global Burden of Disease Study 2019
Background: The association of air pollution with multiple adverse health outcomes is becoming well established, but its negative economic impact is less well appreciated.